Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK
Lynn T. Singer, Derek G. Moore, Meeyoung O. Min, J. Goodwin, J. Turner, Sarah Fulton, Andrew C. Parrott
Human psychopharmacology July 1, 2015 DOI: 10.1002/hup.2459 via Semantic Scholar
Summary
A longitudinal study tracked infants whose mothers used MDMA (ecstasy) during pregnancy to assess developmental effects. The review of findings suggests that prenatal MDMA exposure may be associated with delays in motor development and increased risk of fine motor deficits during infancy. The authors indicate that the observed effects appear to be dose-dependent, with heavier use linked to more pronounced developmental differences. The findings point to potential neurodevelopmental consequences of prenatal MDMA exposure, though the authors note that confounding factors such as other substance use and socioeconomic conditions complicate interpretation.
Study at a glance
| Characteristics | Longitudinal study Peer reviewed |
|---|---|
| Population | Infants with prenatal MDMA exposure |
| Keywords | Medicine Psychology |
| Citations | 16 |
| Key finding | Prenatal MDMA exposure may be associated with motor development delays in infancy, with effects appearing dose-dependent. |
Abstract
This paper aims to review findings from a longitudinal study of prenatal methylenedioxymethamphetamine (MDMA, “ecstasy”) on infant development.